4.6 Review

The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Cytokines, miRNAs, and Antioxidants as Combined Non-invasive Biomarkers for Parkinson's Disease

Amr Ghit et al.

Summary: Parkinson's disease (PD) is a common degenerative disorder of the CNS that primarily affects the human locomotor system. This study aimed to evaluate changes in blood-based biomarkers in PD patients. The results showed an increase in cytokine levels and a positive correlation among them in PD patients. Additionally, an increase in alpha-synuclein protein levels and a decrease in miR-214 levels were observed. Furthermore, decreases in levels of miR-221, miR-141, UA, PON1, and ARE were also found. A mix of noninvasive biomarkers is required to accurately predict disease state and progression in PD.

JOURNAL OF MOLECULAR NEUROSCIENCE (2022)

Article Endocrinology & Metabolism

Circular RNA circ_0070441 regulates MPP+-triggered neurotoxic effect in SH-SY5Y cells via miR-626/IRS2 axis

Xuqing Cao et al.

Summary: In this study, it was found that circ_0070441 exacerbated neurotoxic effects in Parkinson's disease by regulating the miR-626/IRS2 axis. Depletion of circ_0070441 alleviated the neurotoxic effects, indicating its potential as a therapeutic target for PD.

METABOLIC BRAIN DISEASE (2022)

Article Cell Biology

HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models

Peng Lun et al.

Summary: The inhibition of HOTTIP can alleviate neuronal apoptosis and microglial activation in Parkinson's disease models by modulating miR-615-3p/FOXO1.

NEURAL REGENERATION RESEARCH (2022)

Article Cell Biology

Down-regulating Circular RNA Prkcsh suppresses the inflammatory response after spinal cord injury

Jia-Nan Chen et al.

Summary: This study identified differentially expressed circRNAs and miRNAs in a mouse model of spinal cord injury, and found that circPrkcsh regulates the expression of miR-488 and the inflammation-related gene Ccl2. CircRNAs may play a role in the inflammatory response after spinal cord injury and could potentially be used as therapeutic targets for SCI.

NEURAL REGENERATION RESEARCH (2022)

Review Clinical Neurology

The Two Faces of Exosomes in Parkinson's Disease: From Pathology to Therapy

Maria Izco et al.

Summary: Exosomes play a crucial role in Parkinson's disease progression by spreading pathological proteins, activating immune cells, and inducing neuroinflammatory responses; Glial cell-derived exosomes may contribute to the propagation of neuroinflammation; Exosomes have potential as a drug delivery system, especially for targeting therapeutic agents to the brain.

NEUROSCIENTIST (2022)

Article Multidisciplinary Sciences

Early downregulation of hsa-miR-144-3p in serum from drug-naive Parkinson's disease patients

Elisa Zago et al.

Summary: This study aims to investigate the relevance of microRNAs as biomarkers of Parkinson's Disease within the ageing framework. The down-regulation of hsa-miR-144-3p in early Parkinson's Disease patients and its involvement in the regulation of coagulation were consistently observed.

SCIENTIFIC REPORTS (2022)

Article Endocrinology & Metabolism

Expression of BDNF-Associated lncRNAs in Parkinson's disease

Mohammadarian Akbari et al.

Summary: This study measured the expression levels of BDNF and four related long non-coding RNAs in the blood of PD patients and found that all transcripts were down-regulated in PD patients compared to controls. These lncRNA differences may be associated with the pathophysiology of PD and could serve as important biomarkers for PD.

METABOLIC BRAIN DISEASE (2022)

Article Multidisciplinary Sciences

Significant modulations of linc001128 and linc0938 with miR-24-3p and miR-30c-5p in Parkinson disease

Maryam Yousefi et al.

Summary: The research identifies two novel lncRNAs as potential biomarkers for Parkinson's Disease, by evaluating their expression levels in PBMCs to determine their correlation with disease severity.

SCIENTIFIC REPORTS (2022)

Review Geriatrics & Gerontology

Emerging Potential of Exosomal Non-coding RNA in Parkinson's Disease: A Review

Peng Zhang et al.

Summary: This review discusses the significance of non-coding RNAs in exosomes in the pathogenesis of Parkinson's disease and highlights their potential as diagnostic and therapeutic tools, as well as the prospects of bioengineered exosomes.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Clinical Neurology

Diagnostic Test to Identify Parkinson's Disease from the Blood Sera of Chinese Population: A Cross-Sectional Study

Guangan Tong et al.

Summary: This study found that miR-151a-5p, miR-24, mir-485-5p, mir-331-5p, and mir-214 were significantly upregulated in both the serum and CSF exosomes of PD patients, indicating their potential role as biomarkers for PD.

PARKINSONS DISEASE (2022)

Article Neurosciences

Serum microRNA expression levels in Turkish patients with Parkinson's disease

Betul Ozdilek et al.

Summary: The study found that miR-29c expression levels were significantly higher in Turkish Parkinson's disease patients, suggesting it may be a potential diagnostic biomarker. miR-195 showed a significant positive correlation with age, while miR-29a had a significant negative correlation with UPDRS total score.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2021)

Article Biochemistry & Molecular Biology

NEAT1 Decreasing Suppresses Parkinson's Disease Progression via Acting as miR-1301-3p Sponge

Qiang Sun et al.

Summary: Our study demonstrated that decreasing NEAT1 effectively suppressed MPP+-induced neuronal apoptosis. Mechanistically, downregulation of NEAT1 repressed alpha-syn-induced activation of NLRP3 inflammasome via inhibiting the expression of GJB1 by targeting miR-1301-3p. This provides new evidence for lncRNA NEAT1 as a potential therapeutic target for Parkinson's disease.

JOURNAL OF MOLECULAR NEUROSCIENCE (2021)

Article Cell Biology

LncRNA HOTAIR Promotes Neuronal Damage Through Facilitating NLRP3 Mediated-Pyroptosis Activation in Parkinson's Disease via Regulation of miR-326/ELAVL1 Axis

Qian Zhang et al.

Summary: In Parkinson's disease, HOTAIR positively regulates NLRP3-mediated pyroptosis activation through the miR-326/ELAVL1 axis, which significantly inhibits neuronal damage and may contribute to a better understanding of PD pathogenesis and provide new treatment strategies for the disease.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)

Article Neurosciences

Deficiency of NEAT1 prevented MPP+-induced inflammatory response, oxidative stress and apoptosis in dopaminergic SK-N-SH neuroblastoma cells via miR-1277-5p/ARHGAP26 axis

Shufang Zhou et al.

Summary: Noncoding RNAs, specifically NEAT1, play a significant role in MPP+-induced neurotoxicity by regulating miR-1277-5p and ARHGAP26; the upregulation of NEAT1 may contribute to neuron injury induced by MPP+ through the NEAT1-miR-1277-5p-ARHGAP26 ceRNA pathway.

BRAIN RESEARCH (2021)

Article Neurosciences

Up-regulated microRNA-218-5p ameliorates the damage of dopaminergic neurons in rats with Parkinson's disease via suppression of LASP1

Xuelian Ma et al.

Summary: This study demonstrated the protective effect of miR-218-5p on dopaminergic neuron injury in the substantia nigra of rats with PD by regulating LASP1. Up-regulating miR-218-5p or inhibiting LASP1 improved the pathological damage of dopaminergic neurons and suppressed apoptosis and oxidative stress.

BRAIN RESEARCH BULLETIN (2021)

Article Cell Biology

Effective inhibition of miR-330/SHIP1/NF-κB signaling pathway via miR-330 sponge repolarizes microglia differentiation

Yang Feng et al.

Summary: The study investigated the role of microRNA-330 in PD and found that miR-330 sponges could suppress inflammation induced by LPS and provide neuroprotective effects in PD models.

CELL BIOLOGY INTERNATIONAL (2021)

Article Medicine, Research & Experimental

MicroRNA-34a-5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study

Ilaria Grossi et al.

Summary: This exploratory study focused on investigating the differential profile of circulating miR-34a-5p in Parkinson's disease (PD) patients and found that miR-34a-5p was significantly up-regulated in small EVs from PD patients. The study suggests that miR-34a-5p levels in pure SEVs may have a good diagnostic performance in discriminating PD patients from control subjects, and that these levels are associated with disease severity and depression symptoms.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Circulating Extracellular Vesicles: The Missing Link between Physical Exercise and Depression Management?

Edna Soares et al.

Summary: Depression is closely associated with physical exercise and extracellular vesicles, which help reduce systemic inflammation. New discoveries in this field provide new insights into the diagnosis and treatment of depression.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell Biology

LncRNA SNHG1 promotes neuronal injury in Parkinson's disease cell model by miR-181a-5p/CXCL12 axis

Hui Wang et al.

Summary: The study found that SNHG1 promotes MPP+-induced neuronal injury in neuroblastoma cells by regulating the miR-181a-5p/CXCL12 axis, suggesting that SNHG1 may contribute to the development of Parkinson's disease.

JOURNAL OF MOLECULAR HISTOLOGY (2021)

Article Biochemistry & Molecular Biology

MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of Parkinson disease

Qiankun Lv et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by selective loss of dopaminergic neurons. The microRNA miR-3473b has been shown to regulate autophagy and inflammatory factor secretion in PD, indicating a potential therapeutic target for modulating inflammation in Parkinson's disease.

JOURNAL OF NEUROCHEMISTRY (2021)

Article Clinical Neurology

Differentially Expressed Circular RNAs in Peripheral Blood Mononuclear Cells of Patients with Parkinson's Disease

Stylianos Ravanidis et al.

Summary: This study identified specific circRNAs in blood mononuclear cells of patients with Parkinson's disease, which may serve as diagnostic biomarkers for PD. The circRNAs are derived from genes with essential brain functions and may hint on the PD pathways affected.

MOVEMENT DISORDERS (2021)

Article Biochemistry & Molecular Biology

Silencing of UCA1 Protects Against MPP+-Induced Cytotoxicity in SK-N-SH Cells via Modulating KCTD20 Expression by Sponging miR-423-5p

Yanhua Zheng et al.

Summary: This study demonstrated that UCA1 plays a role in Parkinson's disease pathogenesis by modulating the miR-423-5p/KCTD20 axis, thus protecting SK-N-SH cells from MPP+-evoked cytotoxicity.

NEUROCHEMICAL RESEARCH (2021)

Article Biochemistry & Molecular Biology

LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p

Tao Liu et al.

Summary: NEAT1 is highly expressed in PD, and knockdown of NEAT1 can promote cell viability and suppress PD progression through the miR-212-3p/AXIN1 pathway.

NEUROCHEMICAL RESEARCH (2021)

Article Clinical Neurology

LINC00943 knockdown attenuates MPP+-induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells

Chunming Meng et al.

Summary: The study demonstrated that LINC00943 alleviated MPP+-induced neuronal injury through the miR-15b-5p/RAB3IP axis, potentially serving as a promising target for the treatment of Parkinson's disease.

NEUROLOGICAL RESEARCH (2021)

Article Neurosciences

LncRNA OIP5-AS1 reduces α-synuclein aggregation and toxicity by targeting miR-126 to activate PLK2 in human neuroblastoma SH-SY5Y cells

Zhiwei Song et al.

Summary: The study indicates that OIP5-AS1 promotes autophagy of PLK2-alpha-synuclein by targeting the miR-126 axis, reducing the aggregation toxicity of alpha-synuclein. This mechanism helps understand dopaminergic neuron loss in Parkinson's disease and offers potential novel treatment options.

NEUROSCIENCE LETTERS (2021)

Article Neurosciences

SOX21-AS1 modulates neuronal injury of MMP+-treated SH-SY5Y cells via targeting miR-7-5p and inhibiting IRS2

Yang Xie et al.

Summary: The study revealed a new regulatory network involving SOX21-AS1, miR-7-5p, and IRS2 in the pathogenesis of Parkinson's disease. Up-regulation of SOX21-AS1 exacerbated cell injury, while its depletion alleviated cell damage, providing new insights into the mechanism of PD.

NEUROSCIENCE LETTERS (2021)

Article Neurosciences

HMGA1 Induction of miR-103/107 Forms a Negative Feedback Loop to Regulate Autophagy in MPTP Model of Parkinson's Disease

Gehui Li et al.

Summary: Autophagy dysfunction directly related to Parkinson's disease (PD) onset and progression, with high-mobility group A1 (HMGA1) playing a potential neuroprotective role in dopaminergic neurons by modulating autophagy signaling; the miR-103/107 family coordinates proper end-stage autophagy in neurons, while MPP+/MPTP-induced HMGA1 elevation forms a negative feedback loop with miR-103/107 downregulation to regulate autophagy impairment and neural cell death.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Article Biotechnology & Applied Microbiology

Downregulation of microRNA-15b-5p Targeting the Akt3-Mediated GSK-3β/β-Catenin Signaling Pathway Inhibits Cell Apoptosis in Parkinson's Disease

Jianzhong Zhu et al.

Summary: The study found abnormal expression of miR-15b-5p and Akt3 in the serum, cells, and brain tissues of Parkinson's disease patients, affecting the process of cell apoptosis. Inhibiting miR-15b-5p can reduce cell apoptosis in PD, potentially offering new therapeutic targets for the treatment of PD.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Medicine, Research & Experimental

Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect Parkinson's disease

Qiang Li et al.

Summary: Parkinson's disease is the second most common neuro-degenerative disease characterized by irreversible damage of dopamine neurons. Studies have shown that NLRP3 inflammasome and CDK5-mediated autophagy are important in PD. miR-188-3p is a potential therapeutic target for treating PD.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Endocrinology & Metabolism

Downregulation of lncRNA MEG3 is involved in Parkinson's disease

Hui Huang et al.

Summary: In this study, the lncRNA MEG3 was found to be downregulated in PD patients. MEG3 may affect the expression of LRRK2 to regulate cell viability and apoptosis involved in PD.

METABOLIC BRAIN DISEASE (2021)

Article Biochemistry & Molecular Biology

Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases

Daisy Sproviero et al.

Summary: Identifying biomarkers for neurodegenerative diseases through analyzing the miRNA signatures in plasma-derived LEVs and SEVs from AD, PD, ALS, and FTD patients can differentiate various NDs and provide insights into different pathways involved in each disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

MicroRNA-185 activates PI3K/AKT signalling pathway to alleviate dopaminergic neuron damage via targeting IGF1 in Parkinson's disease

Xiaocui Qin et al.

Summary: The study demonstrates that miR-185 ameliorates dopaminergic neuron damage by targeting IGF1 and activating the PI3K/AKT signaling pathway in PD, providing a novel therapeutic approach for PD.

JOURNAL OF DRUG TARGETING (2021)

Article Clinical Neurology

Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study

Ida Manna et al.

Summary: This study demonstrated the potential of exosomal miRNAs as biomarkers to differentiate between Parkinson's disease and Progressive Supranuclear Paralysis, with specific miRNAs like miR-21-3p, miR-22-3p, miR-223-5p, miR-425-5p, miR-21-3p, and miR-199a-5p showing promise in accurate discrimination. The classifier consisting of six exosomal miRNAs had high diagnostic sensitivity and specificity in distinguishing PSP from PD.

PARKINSONISM & RELATED DISORDERS (2021)

Article Genetics & Heredity

Functional Network of the Long Non-coding RNA Growth Arrest-Specific Transcript 5 and Its Interacting Proteins in Senescence

Siqi Wang et al.

Summary: Studies have shown that GAS5 plays a crucial role in brain aging, affecting processes such as cell proliferation and apoptosis. GAS5 may also be associated with senescence-related diseases such as Parkinson's and Alzheimer's.

FRONTIERS IN GENETICS (2021)

Article Biochemistry & Molecular Biology

lncRNA NEAT1 prompts autophagy and apoptosis in MPTP-induced Parkinson's disease by impairing miR-374c-5p

L. Dong et al.

Summary: The study found that NEAT1 levels were significantly correlated with MPTP-induced Parkinson's disease (PD) mice, dopamine neurons, and cells treated with MPP+, and that NEAT1 inhibition effectively promoted cell proliferation, inhibited apoptosis and autophagy. Silencing NEAT1 increased the TH+ rate of neurons and greatly suppressed autophagy. Additionally, NEAT1 may impact apoptosis and autophagy of SH-SY5Y cells through miR-374c-5p.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

Article Geriatrics & Gerontology

Serum miR-214 Serves as a Biomarker for Prodromal Parkinson's Disease

Lanting Li et al.

Summary: miR-214 is significantly upregulated in pPD patients, while miR-31 is significantly upregulated in aPD patients. miR-214 can distinguish pPD patients from controls and may be used as a potential biomarker for pPD diagnosis.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Biotechnology & Applied Microbiology

Screening of Parkinson's Differential MicroRNA Based on GEO Database and Its Clinical Verification

Xuping Jiang et al.

Summary: This study explored the potential difference of miR in PD using GEO data, and found that miR-374a-5p expression was significantly reduced in PD patients and had diagnostic value. The miR-374a-5p may participate in multiple functional pathways.

BIOMED RESEARCH INTERNATIONAL (2021)

Article Neurosciences

Down-regulated long non-coding RNA RMST ameliorates dopaminergic neuron damage in Parkinson's disease rats via regulation of TLR/NF-κB signaling pathway

Xuelian Ma et al.

Summary: Inhibited RMST can attenuate dopaminergic neuron damage in PD rats, possibly through the TLR/NF-κB signaling pathway.

BRAIN RESEARCH BULLETIN (2021)

Article Immunology

Expression Analysis of NF-κB-Related lncRNAs in Parkinson's Disease

Soudeh Ghafouri-Fard et al.

Summary: The study showed significant differences in the expressions of NF-kappa B-related lncRNAs between PD patients and healthy controls, with certain gene expressions being associated with the pathogenesis of PD and correlated with each other. Among the evaluated genes, CEBPA demonstrated the best performance.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Parkinson's Disease Is Associated With Dysregulation of Circulatory Levels of lncRNAs

Kasra Honarmand Tamizkar et al.

Summary: The study revealed differential expression of HULC, PVT1, DSCAM-AS1, SPRY4-IT1, LINC-ROR, and MEG3 lncRNAs in the circulation of PD patients, with MEG3 and LINC-ROR showing higher diagnostic power.

FRONTIERS IN IMMUNOLOGY (2021)

Article Clinical Neurology

Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients

Yanyan Jiang et al.

Summary: The combination of salivary miR-29a-3p and miR-29c-3p shows potential as a diagnostic biomarker for idiopathic PD. The expression level of miR-29a-3p in PD patients was significantly lower than ET patients, but higher than MSA patients.

FRONTIERS IN NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

LINC00943 knockdown exerts neuroprotective effects in Parkinson's disease through regulates CXCL12 expression by sponging miR-7-5p

Han Lian et al.

Summary: The study demonstrated that LINC00943 plays a crucial role in the pathogenesis of PD, and its knockdown attenuates MPP+-triggered neuron injury by regulating the miR-7-5p/CXCL12 axis, indicating a promising therapeutic target for PD treatment.

GENES & GENOMICS (2021)

Article Biochemistry & Molecular Biology

MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease

Xiufeng Wang et al.

Summary: MiR-93 may play a role in PD by regulating the expression of STAT3, with down-regulation of miR-93 expression in LPS-exposed BV2 cells leading to decreased inflammation by inhibiting the expression of iNOS, IL-6 and TNF-alpha.

NEUROCHEMICAL RESEARCH (2021)

Review Neurosciences

MicroRNA Dysregulation in Parkinson's Disease: A Narrative Review

Yong Hui Nies et al.

Summary: Parkinson's disease is a severely debilitating neurodegenerative disease that affects the motor system, with mechanisms of pathogenesis still unclear. MicroRNAs play a crucial role in the regulation of PD-associated genes, dopaminergic neuron survival, and inflammation, potentially serving as diagnostic biomarkers and therapeutic tools for PD.

FRONTIERS IN NEUROSCIENCE (2021)

Article Cell Biology

Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum

Wolfgang P. Ruf et al.

Summary: Cumulative evidence suggests that microRNAs (miRNAs) play a significant role in neurodegenerative diseases, particularly with more pronounced differential expression in the serum of Parkinson's disease patients. The study indicates that miRNA-protein binding may mediate the pathogenic effects of HNF4a, suggesting a complex role for miRNAs in pathology beyond transcriptional dysregulation.

CELLS (2021)

Article Immunology

Circular RNA circZNF652 is overexpressed in osteoarthritis and positively regulates LPS-induced apoptosis of chondrocytes by upregulating PTEN

Xuefeng Yuan et al.

Summary: Circular RNA circZNF652 is overexpressed in osteoarthritis (OA) and positively regulates LPS-induced chondrocyte apoptosis by upregulating PTEN.

AUTOIMMUNITY (2021)

Article Cell Biology

miR-29c-3p regulates TET2 expression and inhibits autophagy process in Parkinson's disease models

Ruili Wang et al.

Summary: In this study, it was found that miR-29c-3p inhibits autophagy in PD models by suppressing TET2 expression. These findings provide new insights for regulating autophagy to improve PD progression.

GENES TO CELLS (2021)

Article Biochemistry & Molecular Biology

Downregulation of long noncoding RNA SNHG7 protects against inflammation and apoptosis in Parkinson's disease model by targeting the miR-425-5p/TRAF5/NF-κB axis

Haiquan Zhang et al.

Summary: Accumulated evidence suggests that the upregulation of lncRNA SNHG7 in Parkinson's disease (PD) may alleviate neuronal apoptosis and microglial activation by modulating inflammation and oxidative stress through the miR-425-5p/TRAF5/NF-kappa B signaling pathway. This study sheds light on the potential therapeutic target for PD.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Article Cell Biology

Plasma hsa-mir-19b is a potential LevoDopa therapy marker

Aimee Rodica Chis et al.

Summary: Parkinson's disease is the second most common neurodegenerative disorder among the elderly, with Levodopa replacement being the gold standard therapy. However, long-term use of Levodopa can lead to severe complications, and there is currently a lack of reliable biomarkers to monitor its efficacy.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Immunology

LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression

Xiaodong Yang et al.

Summary: In this study, we found that the upregulated lncRNA HOXA-AS2 promotes neuroinflammation by regulating microglial polarization through interactions with the PRC2 complex and epigenetically silencing PGC-1α. Therefore, HOXA-AS2 may be a potential therapeutic target for microglia-mediated neuroinflammation in patients with PD.

JOURNAL OF NEUROINFLAMMATION (2021)

Article Medicine, General & Internal

RNA-sequencing of peripheral blood circular RNAs in Parkinson disease

Fancong Kong et al.

Summary: This study characterized the expression profiles of circRNAs and mRNAs in peripheral blood from PD patients, and suggested their potential as biomarkers for PD. By constructing a ceRNA network, the study also revealed the correlation between mRNAs, miRNAs, and circRNAs in the pathogenesis of PD.

MEDICINE (2021)

Article Oncology

Expression levels of specific microRNAs are increased after exercise and are associated with cognitive improvement in Parkinson's disease

Franciele Cascaes Da Silva et al.

Summary: The study showed that interval training can increase the expression levels of miR-106a-5p, miR-103a-3p, and miR-29a-3p in the serum of men with PD, which are associated with cognitive improvement. Further research is needed to explore the potential of these circulating miRNAs as markers for adaptation to physical exercise.

MOLECULAR MEDICINE REPORTS (2021)

Article Oncology

circSAMD4A participates in the apoptosis and autophagy of dopaminergic neurons via the miR-29c-3p-mediated AMPK/mTOR pathway in Parkinson's disease

Wensheng Wang et al.

Summary: This study investigated the pathogenesis of Parkinson's disease and identified that circSAMD4A modulates apoptosis and autophagy of dopaminergic neurons through the AMPK/mTOR cascade via miR-29c-3p in PD.

MOLECULAR MEDICINE REPORTS (2021)

Article Biochemistry & Molecular Biology

Berberine Attenuates MPP+-Induced Neuronal Injury by Regulating LINC00943/miR-142-5p/KPNA4/NF-κB Pathway in SK-N-SH Cells

Xueqin Li et al.

Summary: The study found that berberine exerts a neuro-protective role in Parkinson's disease by modulating the LINC00943/miR-142-5p/KPNA4/NF-kappa B pathway.

NEUROCHEMICAL RESEARCH (2021)

Article Clinical Neurology

Differential expression of gut miRNAs in idiopathic Parkinson's disease

Anna Kurz et al.

Summary: This study identified an enrichment of miR-486-5p in routine colonic biopsies from PD patients, with its expression correlating with age and disease severity. Analysis revealed 301 gene targets affected by miR-486-5p, indicating their role in biological processes in the enteric nervous system (ENS). These findings suggest the potential of miR-486-5p as a biomarker for PD and provide insights into the molecular mechanisms of GI dysfunction in PD.

PARKINSONISM & RELATED DISORDERS (2021)

Article Multidisciplinary Sciences

Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease

Qihua Chen et al.

Summary: Elevated levels of miR-133b and miR-221-3p showed high sensitivity and specificity in distinguishing early-stage PD patients from controls, suggesting their potential as biomarkers for early PD. Additionally, miR-4454 demonstrated the ability to differentiate between PD and MSA. These findings highlight the potential of miRNAs as non-invasive biomarkers for PD diagnosis.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Long Noncoding RNA NEAT1 Knockdown Ameliorates 1-Methyl-4-Phenylpyridine-Induced Cell Injury Through MicroRNA-519a-3p/SP1 Axis in Parkinson Disease

Shuihua Wang et al.

Summary: NEAT1 silencing protects against MPP+-induced neuroblastoma cell injury by regulating the miR-519a-3p/SP1 pathway, showing a potential therapeutic target for Parkinson's disease.

WORLD NEUROSURGERY (2021)

Article Geriatrics & Gerontology

Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease

Annamaria Vallelunga et al.

Summary: This study investigated miR-96-5p and miR-339-5p as novel biomarkers for the differential diagnosis between PD and MSA. MiR-96-5p was significantly increased in MSA patients compared to PD and HC, while miR-339-5p showed a significant increase in MSA patients compared to both PD and HC groups.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Neurosciences

Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease

Shulei He et al.

Summary: This study identified 6 serum EV-derived miRNAs that may serve as potential biomarkers for PD progression and early diagnosis in populations, demonstrating their potential clinical utility.

TRANSLATIONAL NEURODEGENERATION (2021)

Article Cell Biology

Aberrant Expression of Circulating MicroRNA Leads to the Dysregulation of Alpha-Synuclein and Other Pathogenic Genes in Parkinson's Disease

Meng Cai et al.

Summary: A comprehensive study revealed the expression profiles of circulating miRNAs in Parkinson's disease patients, showing enrichment of miRNA target genes in various signaling pathways. The study further examined the regulatory network of these miRNAs and their PD-related gene targets in human neural stem cells. The findings identified potential biomarkers and therapeutic targets for Parkinson's disease.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biotechnology & Applied Microbiology

Long noncoding RNA SRY-box transcription factor 2 overlapping transcript participates in Parkinson's disease by regulating the microRNA-942-5p/nuclear apoptosis-inducing factor 1 axis

Yabi Guo et al.

Summary: The study demonstrated that lncRNA SOX2-OT regulates oxidative stress, inflammation, and neuronal apoptosis through the miR-942-5p/NAIF1 signaling axis in MPP+-induced SH-SY5Y cells, highlighting a potential mechanism underlying Parkinson's disease.

BIOENGINEERED (2021)

Article Oncology

Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson's disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein

Hai Wang et al.

Summary: The study elucidated the relationship and mechanism of SNHG1 and miR-216a-3p in Parkinson's disease (PD), revealing their regulatory roles in cell activity and apoptosis. BAX plays a crucial role in this regulatory network.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Clinical Neurology

Long Noncoding RNA SNHG1 Knockdown Ameliorates Apoptosis, Oxidative Stress and Inflammation in Models of Parkinson's Disease by Inhibiting the miR-125b-5p/MAPK1 Axis

Xiao Xiao et al.

Summary: The study revealed that SNHG1 plays a critical role in the pathogenesis of PD, and its knockdown exerted neuroprotective effects against MPP+-induced cytotoxicity. SNHG1 acts as a molecular sponge of miR-125b-5p and regulates the miR-125b-5p/MAPK1 axis, highlighting a potential therapeutic target for PD therapy.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2021)

Article Biology

Long non-coding RNA MALAT1 regulates cell proliferation and apoptosis via miR-135b-5p/GPNMB axis in Parkinson's disease cell model

Kefeng Lv et al.

Summary: The study revealed that MALAT1 regulates cell proliferation and apoptosis in MPP+-stimulated cell model of PD through the miR-135b-5p/GPNMB axis, suggesting MALAT1 as a potential biomarker and therapeutic target for PD.

BIOLOGICAL RESEARCH (2021)

Article Biotechnology & Applied Microbiology

Long non-coding RNA nuclear enriched abundant transcript 1 (NEAT1) sponges microRNA-124-3p to up-regulate phosphodiesterase 4B (PDE4B) to accelerate the progression of Parkinson's disease

Ming-Yu Chen et al.

Summary: The study demonstrated that depletion of NEAT1 in Parkinson's disease cell models increased cell viability, reduced cell injury and inflammatory response by regulating the expression levels of miR-124-3p and PDE4B. NEAT1 was identified as a promising target for treating PD.

BIOENGINEERED (2021)

Article Biochemistry & Molecular Biology

Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson's disease

Zhong Feng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Editorial Material Cell Biology

IFNB/interferon-β regulates autophagy via a MIR1-TBC1D15-RAB7 pathway

Patrick Ejlerskov et al.

AUTOPHAGY (2020)

Article Endocrinology & Metabolism

MicroRNA-216a inhibits neuronal apoptosis in a cellular Parkinson's disease model by targeting Bax

Xiaobo Yang et al.

METABOLIC BRAIN DISEASE (2020)

Article Biochemistry & Molecular Biology

Astrocyte-Derived Exosomal microRNA miR-200a-3p Prevents MPP+-Induced Apoptotic Cell Death Through Down-Regulation of MKK4

Norshalena Shakespear et al.

NEUROCHEMICAL RESEARCH (2020)

Review Neurosciences

Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders

M. M. J. van den Berg et al.

PROGRESS IN NEUROBIOLOGY (2020)

Article Genetics & Heredity

MicroRNA-150 serves as a diagnostic biomarker and is involved in the inflammatory pathogenesis of Parkinson's disease

Haiting Li et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2020)

Article Toxicology

Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration

Abhishek Jauhari et al.

TOXICOLOGICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

LncRNA HULC induces the progression of osteosarcoma by regulating the miR-372-3p/HMGB1 signalling axis

Yong Li et al.

MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

LncRNA H19 Attenuates Apoptosis in MPTP-Induced Parkinson's Disease Through Regulating miR-585-3p/PIK3R3

Yong Zhang et al.

NEUROCHEMICAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology

Sara R. Oliveira et al.

BIOMOLECULES (2020)

Article Medicine, Research & Experimental

Down regulation of miR-218, miR-124, and miR-144 relates to Parkinson's disease via activating NF-κB signaling

Rui-Xian Xing et al.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2020)

Article Biotechnology & Applied Microbiology

Long-Noncoding RNA TUG1Promotes Parkinson's Disease via ModulatingMiR-152-3p/PTENPathway

Kaihua Zhai et al.

HUMAN GENE THERAPY (2020)

Article Medicine, Research & Experimental

Tetramethylpyrazine ameliorates isoflurane-induced cognitive dysfunction by inhibiting neuroinflammation via miR-150 in rats

Huaqing Cui et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)

Article Clinical Neurology

Validation of differentially expressed brain-enriched microRNAs in the plasma of PD patients

Stylianos Ravanidis et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Geriatrics & Gerontology

LncRNA-T199678 Mitigates α-Synuclein-Induced Dopaminergic Neuron Injury via miR-101-3p

Lu-Lu Bu et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Clinical Neurology

Association of the Plasma Long Non-coding RNA MEG3 With Parkinson's Disease

Yi Quan et al.

FRONTIERS IN NEUROLOGY (2020)

Article Cell Biology

FAIM Is Regulated by MiR-206, MiR-1-3p and MiR-133b

Elena Coccia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Environmental Sciences

Overexpression of miR-138-5p suppresses MnCl2-induced autophagy by targeting SIRT1 in SH-SY5Y cells

Junxiang Ma et al.

ENVIRONMENTAL TOXICOLOGY (2019)

Article Geriatrics & Gerontology

Plasma microRNA profiling distinguishes patients with frontotemporal dementia from healthy subjects

Margherita Grasso et al.

NEUROBIOLOGY OF AGING (2019)

Article Cell Biology

Triptolide Inhibits Preformed Fibril-Induced Microglial Activation by Targeting the MicroRNA155-5p/SHIP1 Pathway

Yang Feng et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Biochemistry & Molecular Biology

Long non-coding RNA-p21 regulates MPP+-induced neuronal injury by targeting miR-625 and derepressing TRPM2 in SH-SY5Y cells

Xiu-Ming Ding et al.

CHEMICO-BIOLOGICAL INTERACTIONS (2019)

Review Biochemistry & Molecular Biology

Past, present, and future of circRNAs

Ines Lucia Patop et al.

EMBO JOURNAL (2019)

Article Biochemistry & Molecular Biology

miR-let-7a suppresses α-Synuclein-induced microglia inflammation through targeting STAT3 in Parkinson's disease

Jianzhong Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Article Biochemistry & Molecular Biology

LncRNA HOTAIR targets miR-126-5p to promote the progression of Parkinson's disease through RAB3IP

Qiuyu Lin et al.

BIOLOGICAL CHEMISTRY (2019)

Article Clinical Neurology

Preliminary study of hsa-miR-626 change in the cerebrospinal fluid of Parkinson's disease patients

Li-xia Qin et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2019)

Review Genetics & Heredity

The biogenesis, biology and characterization of circular RNAs

Lasse S. Kristensen et al.

NATURE REVIEWS GENETICS (2019)

Article Medicine, Research & Experimental

Downregulation of miR-21 suppresses 1-methyl-4-phenylpyridinium-induced neuronal damage in MES23.5 cells

Huawu Mao et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)

Article Immunology

Long non-coding RNA Mirt2 prevents TNF-α-triggered inflammation via the repression of microRNA-101

Yingying Han et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

Article Neurosciences

Epigenetic Control of Rho-Associated Protein Kinase 2 in Neurodegeneration

Bing Chen et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Biochemistry & Molecular Biology

Long noncoding RNA NORAD regulates MPP plus -induced Parkinson's disease model cells

Qingxin Song et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2019)

Article Medicine, Research & Experimental

Overexpression of microRNA-183 promotes apoptosis of substantia nigra neurons via the inhibition of OSMR in a mouse model of Parkinson's disease

Jin-Xia Gao et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2019)

Article Clinical Neurology

The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes

Charlotte Starhof et al.

MOVEMENT DISORDERS (2019)

Article Biochemistry & Molecular Biology

LncRNA NEAT1 promotes autophagy in MPTP-induced Parkinson's disease through stabilizing PINK1 protein

Wang Yan et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease

Youwen Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Biochemistry & Molecular Biology

Metazoan MicroRNAs

David P. Bartel

Article Pharmacology & Pharmacy

Long non-coding RNA NEAT1 mediates the toxic of Parkinson's disease induced by MPTP/MPP plus via regulation of gene expression

Ying Liu et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)

Article Biochemistry & Molecular Biology

Exploring microRNA Biomarker for Amyotrophic Lateral Sclerosis

Y-h. Taguchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemical Research Methods

Cell-type specific sequencing of microRNAs from complex animal tissues

Chiara Alberti et al.

NATURE METHODS (2018)

Article Medicine, Research & Experimental

Inhibition of microRNA-155 modulates endotoxin tolerance by upregulating suppressor of cytokine signaling 1 in microglia

Xiaolei Sun et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)

Article Cell & Tissue Engineering

miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation

Roberto De Gregorio et al.

STEM CELL REPORTS (2018)

Article Immunology

Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice

Nellie A. Martin et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Endocrinology & Metabolism

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Jacob O'Brien et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Article Medicine, General & Internal

Protective role of microRNA-221 in Parkinson's disease

L. Li et al.

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY (2018)

Article Pharmacology & Pharmacy

MiR-30a-5p ameliorates spinal cord injury-induced inflammatory responses and oxidative stress by targeting Neurod 1 through MAPK/ERK signalling

Xiaodong Fu et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2018)

Article Biochemistry & Molecular Biology

Analysis of Epidermal Growth Factor Receptor Related Gene Expression Changes in a Cellular and Animal Model of Parkinson's Disease

In-Su Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Biotechnology & Applied Microbiology

Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo

Kirsty J. McMillan et al.

MOLECULAR THERAPY (2017)

Article Biotechnology & Applied Microbiology

Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model

Pia Rivetti di Val Cervo et al.

NATURE BIOTECHNOLOGY (2017)

Review Biochemistry & Molecular Biology

LncRNA-mediated regulation of cell signaling in cancer

W-X Peng et al.

ONCOGENE (2017)

Review Pharmacology & Pharmacy

Exosome-Encapsulated microRNAs as Potential Circulating Biomarkers in Colon Cancer

Mina Hosseini et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Biotechnology & Applied Microbiology

miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells

Jianlei Zhang et al.

DISEASE MARKERS (2017)

Review Biochemistry & Molecular Biology

Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Subodh Kumar et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Chemistry, Multidisciplinary

MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease

C. Saraiva et al.

JOURNAL OF CONTROLLED RELEASE (2016)

Article Biochemistry & Molecular Biology

Inhibition of MicroRNA-221 Alleviates Neuropathic Pain Through Targeting Suppressor of Cytokine Signaling 1

Li Xia et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2016)

Review Cell Biology

The biogenesis and emerging roles of circular RNAs

Ling-Ling Chen

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Glycine inhibits ethanol-induced oxidative stress, neuroinflammation and apoptotic neurodegeneration in postnatal rat brain

Faiz Ul Amin et al.

NEUROCHEMISTRY INTERNATIONAL (2016)

Review Multidisciplinary Sciences

How neuroinflammation contributes to neurodegeneration

Richard M. Ransohoff

SCIENCE (2016)

Review Biochemistry & Molecular Biology

The emerging role of IncRNAs in cancer

Maite Huarte

NATURE MEDICINE (2015)

Article Clinical Neurology

miRNA expression is highly sensitive to a drug therapy in Parkinson's disease

Anelya Kh. Alieva et al.

PARKINSONISM & RELATED DISORDERS (2015)

Review Biochemistry & Molecular Biology

The Noncoding RNA Revolution-Trashing Old Rules to Forge New Ones

Thomas R. Cech et al.

Article Medicine, Research & Experimental

Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia

A. Kalani et al.

LIFE SCIENCES (2014)

Review Genetics & Heredity

The rise of regulatory RNA

Kevin V. Morris et al.

NATURE REVIEWS GENETICS (2014)

Review Genetics & Heredity

Non-viral vectors for gene-based therapy

Hao Yin et al.

NATURE REVIEWS GENETICS (2014)

Article Multidisciplinary Sciences

Studying the System-Level Involvement of MicroRNAs in Parkinson's Disease

Paulami Chatterjee et al.

PLOS ONE (2014)

Article Biochemistry & Molecular Biology

MicroRNA-205 regulates the expression of Parkinsons disease-related leucine-rich repeat kinase 2 protein

Hyun Jin Cho et al.

HUMAN MOLECULAR GENETICS (2013)

Article Multidisciplinary Sciences

Natural RNA circles function as efficient microRNA sponges

Thomas B. Hansen et al.

NATURE (2013)

Article Multidisciplinary Sciences

TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity

Mickael Decressac et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Biochemistry & Molecular Biology

Extracellular miRNAs: the mystery of their origin and function

Andrey Turchinovich et al.

TRENDS IN BIOCHEMICAL SCIENCES (2012)

Review Neurosciences

MicroRNAs and deregulated gene expression networks in neurodegeneration

Kai-Christian Sonntag

BRAIN RESEARCH (2010)

Review Cell & Tissue Engineering

MicroRNAs as Regulators of Differentiation and Cell Fate Decisions

Kathryn N. Ivey et al.

CELL STEM CELL (2010)

Article Multidisciplinary Sciences

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

Rajnish A. Gupta et al.

NATURE (2010)

News Item Multidisciplinary Sciences

Shining a Light on the Genome's 'Dark Matter'

Elizabeth Pennisi

SCIENCE (2010)

Review Genetics & Heredity

Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders

Cecilia Lundberg et al.

CURRENT GENE THERAPY (2008)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Article Clinical Neurology

The rotenone model of Parkinson's disease: genes, environment and mitochondria

JT Greenamyre et al.

PARKINSONISM & RELATED DISORDERS (2003)